How to Help Your Patients Find Thyrogen Kit in Stock: A Provider's Guide

When patients with differentiated thyroid cancer run into barriers accessing Thyrogen Kit (thyrotropin alfa), they often turn to their endocrinologist or nuclear medicine team for help. As the provider, you are frequently the most effective person in the room for navigating specialty pharmacy logistics, insurance hurdles, and manufacturer support programs. This guide gives you the tools and workflows to help your patients access Thyrogen Kit with minimal delay.

Understanding the Thyrogen Kit Supply Chain

Thyrogen Kit is not a pharmacy shelf drug. As a specialty biologic manufactured exclusively by Sanofi Genzyme, it flows through a restricted distribution network. For most practices, Thyrogen arrives via one of three pathways:

Hospital pharmacy supply: Academic medical centers and large hospital systems often have Thyrogen in formulary through their nuclear medicine or endocrinology departments. Patients using facilities affiliated with a major health system have the most reliable access pathway.

Specialty pharmacy delivery to the clinic: Private practices and standalone endocrinology offices typically order Thyrogen through specialty pharmacies such as CVS Specialty, Accredo, or AllianceRx Walgreens Prime. The drug is shipped directly to the practice for in-office administration.

Direct manufacturer ordering (ThyrogenONE): In some cases, Sanofi Genzyme's ThyrogenONE program can facilitate direct order placement or help connect the practice with a distributor that has current stock.

Step-by-Step: How to Secure Thyrogen Kit for a Patient

Step 1: Initiate Prior Authorization Immediately After Scheduling

The single most common cause of Thyrogen access delay is late prior authorization initiation. The moment a Thyrogen-stimulated procedure is placed on the calendar — regardless of how far out — your prior auth workflow should begin. For commercial insurance, this process typically takes 2–4 weeks. Medicare Part B covers Thyrogen when administered in an outpatient or physician office setting and generally does not require the same prior authorization hurdles as commercial plans, but coverage should still be verified.

Documentation typically required for prior auth includes:

Diagnosis of well-differentiated thyroid cancer (DTC) with prior thyroidectomy

Clinical indication (Tg surveillance, RAI ablation preparation)

Attestation that the indication meets coverage criteria (e.g., absence of distant metastases for ablation use)

Step 2: Order Through Your Specialty Pharmacy Partner

Once insurance authorization is secured (or confirmed for Medicare Part B), place the Thyrogen order through your specialty pharmacy. Allow a minimum of 1–2 weeks for sourcing and delivery. Thyrogen must be stored refrigerated at 2–8°C upon arrival and must be used before its expiration date. Coordinate your specialty pharmacy order with your procedure scheduling to minimize drug waste from timing mismatches.

Step 3: Call ThyrogenONE If Supply Is Delayed

If your specialty pharmacy cannot source Thyrogen within the required timeframe, call ThyrogenONE at 1-888-497-6436. The ThyrogenONE team includes case managers who can:

Identify alternative specialty pharmacies or distributors with current stock

Assist with insurance navigation and prior authorization appeals

Connect patients with financial assistance programs

Step 4: Direct Patients to medfinder

For patients who are proactively searching for Thyrogen availability, medfinder for providers is a practical resource. medfinder contacts pharmacies and specialty distributors in the patient's area to determine which locations can fill the prescription. This is especially helpful for patients who may be traveling or whose usual facility is experiencing logistics delays.

Managing Patient Expectations and Communication

Patients who have been through thyroid cancer treatment are often anxious about their follow-up surveillance timing. When access barriers arise, proactive and transparent communication is essential:

Explain the reason for any delay clearly and honestly — do not let administrative issues go unexplained

Provide a realistic revised timeline and follow up proactively

Discuss the THW backup option early if there is any risk of Thyrogen not being available in time, so patients are not surprised by a protocol change

Reassure patients that brief, medically acceptable delays do not typically affect outcomes for low-risk patients with excellent response status

Supporting Patient Financial Access

For a detailed look at how to help patients manage the cost of Thyrogen Kit, see our companion guide: How to help your patients save money on Thyrogen Kit. Key programs include the Thyrogen Co-Pay Assistance Program (up to $1,000 for commercially insured patients) and the Sanofi Patient Connection Patient Assistance Program for uninsured/underinsured patients.

For provider-specific tools and support, visit medfinder for providers to access resources designed specifically for clinical teams navigating medication availability challenges.